Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With C — 2017 Double Blind Clinical Trial | BudProfiles

Home

Studies

Fatty Acid Amide Hydrolase Inhibitor Treatment in ...

InconclusiveDouble Blind Clinical Trial2017

Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial

View Study

Classification Results

AI Classification

Inconclusive

Fine-tuned Classification

N/A

Conditions Studied

Urinary Tract Infection

Related Studies

Positive

Cannabinoids and bladder symptoms in multiple sclerosis

2021·Review/Other

Inconclusive

The endocannabinoid system, cannabis, and cannabidiol: Implications in urology and men's health

2021·Animal Study - Veterinary Clinical Trial

Positive

The urothelium, the urinary microbioma and men LUTS: a systematic review

2020·Meta-analysis -

Positive

Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome

2019·Review/Other

Positive

The Association Between Tetrahydrocannabinol and Lower Urinary Tract Symptoms Utilizing the National Health and Nutrition Examination Survey

2019·Review/Other

Positive

The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial

2017·Clinical Trial

Cannabinoids

Fatty Acid Amide Hydrolase (FAAH)

Organ Systems

Urinary System

Study Details

Type: Double Blind Clinical Trial
Year: 2017
Study ID: #2017033